Open Access Open Access  Restricted Access Subscription or Fee Access

Brief Introduction of Acinetobacter baumannii bacterial species

Deepak Chaudhary

Abstract


Acinetobacter baumannii is an opportunistic human pathogen that causes potentially fatal nosocomial infections include ventilator-associated pneumonia, bacteremia, meningitis, urinary tract infections, and wound infections. Infections produced by multi-drug resistance (MDR) A. baumannii strains have few treatment choices. Biofilm generation, serum resistance, motility, efflux pumps, and iron acquisition processes all assist the bacteria survive in harsh environments and enable infection progression. The purpose of this study was to look at the fundamental traits that lead to the virulence of clinically  significant MDR A. baumannii isolates. MDR A. baumannii strains are among the most common nosocomial infection agents in our hospital and throughout the world.


Keywords


Acinetobacter baumannii, pathogen, MDR, strains, Bacterial infection

Full Text:

PDF

References


Beijerinck MW. Pigmenten als oxydatieproducten gevormd door bacterien. Versl Koninklijke Akad Wetensch 1911; 19:1092–103.

Gould IM. The epidemiology of antibiotic resistance. Int J Antimicrob Agents 2008;32(Suppl. 1): S2–9.

Vallenet D, Nordmann P, Barbe V, Poirel L, Mangenot S, Bataille E, et al. Comparative analysis of acinetobacters: three genomes for three lifestyles. PLoS One 2008;19: e1805.

Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, et al. new insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 2007; 21:601–14.

Lee HW, Kah YM, Kim J, Lee JC, Seol SY, Cho DT, et al. Capacity of multidrugresistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin Microbiol Infect

; 14:49–54.

Cevahir N, Demir M, Kaleli I, Gurbuz M, Tikvesli S. Evaluation of biofilm production, gelatinase activity, and mannose-resistant haemagglutination in Acinetobacter baumannii strains. J Microbiol Immunol Infect 2008; 41:513–8.

Vidal R, Dominguez M, Urrutia H, Bello H, Gonzalez G, Garcia A, et al. Biofilm formation by Acinetobacter baumannii. Microbios 1996; 86:49–58.

Gaddy JA, Actis LA. Regulation of Acinetobacter baumannii biofilm formation. Future Microbiol 2009;4:273–8.

Siroy A, Cosette P, Seyer D, Lemaître-Guillier C, Vallenet D, Van Dorsselaer A, et al. Global comparison of the membrane subproteomes between a multidrugresistant Acinetobacter baumannii strain and a reference strain. J Proteome Res 2006; 5:3385–98.

Rodríguez-Bano J, Martí S, Soto S, Fernández-Cuenca F, Cisneros JM, Pachón ˜ J, et al. Biofilm formation in Acinetobacter baumannii: associated features and clinical implications. Clin Microbiol Infect 2008;14:276–8.

Lee JC, Koerten H, van den Broek P, Beekhuizen H, Wolterbeek R, van den Barselaar M, et al. Adherence of Acinetobacter baumannii strains to human bronchial epithelial cells. Res Microbiol 2006; 157:360–6.

de Breij A, Gaddy J, van der Meer J, Koning R, Koster A, van den Broek P, et al. CsuA/BABCDE- dependent pili are not involved in the adherence of Acinetobacter baumannii ATCC19606(T) to human airway epithelial cells and their inflammatory response. Res Microbiol 2009; 160:213–8.

Choi CH, Lee JS, Lee YC, Park TI, Lee JC. Acinetobacter baumannii epithelial cells and outer membrane protein A mediates interactions with epithelial cells. BMC Microbiol 2008; 8:216.

Choi CH, Lee EY, Lee YC, Park TI, Kim HJ, Hyun SH, et al. Outer membrane protein 38 of Acinetobacter baumannii localizes to the mitochondria and induces apoptosis of epithelial cells. Cell Microbiol 2005;7:1127–38.

Choi CH, Hyun SH, Lee JY, Lee JS, Lee YS, Kim SA, et al. Acinetobacter baumannii outer membrane protein A targets the nucleus and induces cytotoxicity. Cell Microbiol 2008; 10:309–19.

Lee JS, Lee JC, Lee CM, Jung ID, Jeong YI, Seong EY, et al. Outer membrane protein A of Acinetobacter baumannii induces differentiation of CD4+ T cells toward a Th1 polarizing phenotype through the activation of dendritic cells. Biochem Pharmacol 2007; 74:86–97.

Kim SA, Yoo SM, Hyun SH, Choi CH, Yang SY, Kim HJ, et al. Global gene expression patterns and induction of innate immune response in human laryngeal epithelial cells in response to Acinetobacter baumannii outer membrane protein A. FEMS Immunol Med Microbiol 2008;54:45–52.

Zimbler DL, Penwell WF, Gaddy JA, Menke SM, Tomaras AP, Connerly PL, et al. Iron acquisition functions expressed by the human pathogen Acinetobacter baumannii. Biometals 2009; 22:23–32.

Dorsey CW, Beglin MS, Actis LA. Detection, and analysis of iron uptake components expressed by Acinetobacter baumannii clinical isolates. J Clin Microbiol 2003; 41:4188–93.

Smith AW, Alpar KE. Immune response to Acinetobacter calcoaceticus infection in man. J Med Microbiol 1991; 34:83–8.


Refbacks

  • There are currently no refbacks.